Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan

Journal of Applied Polymer Science

Volumn 130, Issue 2, 2013, Pages 927-932

  Dong, Zhikui ^a   Zheng, Wenyi ^a   Xu, Zaiyang ^a   Yin, Zongning ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

drug delivery systems; polysaccharides; synthesis and processing

Indexed keywords

5-FLUOROURACIL (5-FU); ACIDIC ENVIRONMENT; ANTI-CANCER THERAPIES; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; ENZYMATIC CLEAVAGE; PHOSPHATE-BUFFERED SALINES; SYNTHESIS AND PROCESSING;

CELL CULTURE; DRUG DELIVERY; PLASMA STABILITY; PLASMAS; POLYSACCHARIDES; TUMORS;

HYALURONIC ACID;

EID: 84880917059     PISSN: 00218995     EISSN: 10974628     Source Type: Journal    
DOI: 10.1002/app.39247     Document Type: Article

References (22)

1. Longley, D. B.; Harkin, D. P.; Johnston, P. G., Nat. Rev. Cancer 2003, 3, 330.
2. Presant, C. A.; Jacobson, J.; Wolf, W.; Waluch, V.; Weitz, I. C.; Macdonald, J. S.,; Southwest Oncology Group. Invest. New Drugs 2002, 20, 369.
3. Jaracz, S.; Chen, J.; Kuznetsova, L. V.; Ojima, I., Bioorg. Med. Chem. 2005, 13, 5043.
4. Pan, X.; Wang, C.; Wang, F.; Li, P.; Hu, Z.; Shan, Y.; Zhang, J., Curr. Med. Chem. 2011, 18, 4538.
5. Casado, E.; Pfeiffer, P.; Feliu, J.; González-Barõn, M.; Vestermark, L.; Jensen, H. A., Ann. Oncol. 2008, 19, 1371.
6. Kuzuhara, S.; Ohkoshi, N.; Kanemaru, K.; Hashimoto, H.; Nakanishi, T.; Toyokura, Y. J., Neurol. 1987, 234, 365.
7. Koukourakis, G. V.; Kouloulias, V.; Koukourakis, M. J.; Zacharias, G. A.; Zabatis, H.; Kouvaris, J., Molecules 2008, 13, 1897.
8. Yuan, F.; Qin, X.; Zhou, D.; Xiang, Q. Y.; Wang, M. T.; Zhang, Z. R.; Huang, Y., Eur. J., Pharm. Biopharm. 2008, 70, 770.
9. Petrak, K.; Goddard, P., Adv. Drug Deliv. Rev. 1989, 3, 191.
10. Takakura, Y.; Hashida, M., Crit. Rev. Oncol. Hematol. 1995, 18, 207.
11. David, A.; Kopecková, P.; Minko, T.; Rubinstein, A.; Kopecek, J., Eur. J. Cancer 2004, 40, 148.
12. Duan, L.; Zheng, Q.; Li, X.; Quan, D.; Ge, J. J., Control Release 2011, 152, 18.
13. Lee, J.; Rho, J.; Yang, Y.; Kong, H.; Jung, Y.; Kim, Y. J., Drug Target 2007, 15, 199.
14. Toole, B. P., Nat. Rev. Cancer 2004, 4, 528.
15. Misra, S.; Heldin, P.; Hascall, V. C.; Karamanos, N. K.; Skandalis, S. S.; Markwald, R. R.; Ghatak, S., FEBS J. 2011, 278, 1429.
16. Galer, C. E.; Sano, D.; Ghosh, S. C.; Hah, J. H.; Auzenne, E.; Hamir, A. N.; Myers, J. N.; Klostergaard, J., Oral Oncol. 2011, 47, 1039.
17. DufaÿWojcicki, A.; Hillaireau, H.; Nascimento, T. L.; Arpicco, S.; Taverna, M.; Ribes, S.; Bourge, M.; Nicolas, V.; Bochot, A.; Vauthier, C.; Tsapis, N.; Fattal, E. J., Control Release 2012, 162, 545.
18. Platt, V. M.; Szoka, F. C., Jr,. Mol. Pharm. 2008, 5, 474.
19. Yang, Y. W.; Lee, J. S.; Kim, I.; Jung, Y. J.; Kim, Y. M., Eur. J. Pharm. Biopharm. 2007, 66, 260.
20. Sun, Y. W.; Chen, K. M.; Kwon, C. H., Mol. Pharm. 2006, 3, 161.
21. Kopecek, J.; Kopecková, P.; Minko, T.; Lu, Z., Eur. J. Pharm. Biopharm. 2000, 50, 61.
22. Nakashima, M.; Nakano, T.; Ametani, Y.; Funamoto, H.; Uchiyama, A.; Miwa, A.; Miyata, S.; Shoji, M.; Kondo, T.; Satake, S.; Kojima, Y., Int. J. Gynecol. Cancer 2006, 16, 1309.